Functional magnetic resonance imaging (MRI) of tumors of the head and neck usually encompasses diffusion-weighted imaging (DWI) and intravenous (IV) contrast T1 dynamic perfusion imaging (DCE-MRI or PWI). Both techniques can characterize different tissues by probing into their microstructure, providing a novel approach in oncological imaging. In this pictorial review, we will cover the important technical aspects of DWI and PWI, the pathophysiological background and the current applications and potential of these functional MRI techniques in the imaging of head and neck cancer.
Introduction
Functional magnetic resonance imaging (MRI) of tumors of the head and neck includes diffusionweighted imaging (DWI) and intravenous (IV) contrast T1 dynamic perfusion imaging (dynamic contrastenhanced (DCE)-MRI or PWI). The implementation of these techniques is currently limited to a small number of head and neck imaging academic practices. The cost of software packages for performing perfusion analysis, and the time and expertise required for this prohibits the widespread use of the technique in community/private practices. However, DWI requires little time and is incorporated into the basic manufacturers' packages, so that it is more widely used. This article provides an overview of both these techniques and their potential benefits as problem-solving tools in head and neck cancer imaging.
DWI: important technical aspects
The basic principles of DWI have been extensively covered in the literature. 1 Clinical applications for DWI MRI in the head and neck region have been limited because echoplanar diffusion-weighted MRI in this region has several inherent drawbacks, including susceptibility of artifacts due to the anatomic heterogeneity of the area, the presence of dental work, as well as adjacent air and bone. 2 Important technical considerations in applying DWI include inferior saturation block to minimize pulsation artifacts, adding a posterior saturation band to eliminate the susceptibility from the posterior neck soft tissues-fat interface, manual shimming to avoid air containing or moving parts (improving homogeneity) and reducing fat shift and distortion artifacts. A shim should cover the spine and muscles of the neck while avoiding large areas of air. The phase encoding direction should be anterior to posterior (A-P) to minimize distortion. Moreover, imaging is best carried out in two groups in the upper (face) and lower neck with two different shimming blocks to compensate for the shape and thickness of different tissue parts (Figure 1 ).
An echoplanar imaging EPI-DWI is applied, with an apparent diffusion coefficient (ADC) calculation usually carried out using a mono-exponential model [S ¼ S0 Â exp (Àb Â ADC)], where signal intensity (SI) is measured with at least two different b-values (s/mm 2 ). For instance, 0, 50, 100, 500,750, and 1000 b-values (s/mm 2 ) are plotted for estimated SI (ADC average; Figure 2 ). The influence of b-value choice on the calculated ADC has been studied by Thoeny et al. 3 and Vandecaveye et al. 4 Using a large range of b-values (0, 50,. . .,1000) leads to different ADCs with low (0, 50, 100) and high (500, 750, 1000) b-value settings providing different information, and reflects contributions from diffusion and perfusion. Vandecaveye et al. 4 showed that the choice of different sets of b-values to calculate ADC can result in different interpretation of the data. Using ADC b0-1000 showed a sensitivity (SN) of 83% and specificity (SP) 94%, ADC b0-100 showed SN 79% and SP 67%, probably due to contamination by micro perfusion, and ADC b500-1000 showed SN 72% and SP 67% due to the influence of noise. Care should be taken in placing the region of interest (ROI) measurement in the tumor, to include the solid portions and exclude necrotic or cystic regions in reference to T2-weighted and gadoliniumenhanced T1-weighted MRI. A crucial consideration is Figure 1 . Important technical aspects in DWI: Saturation block to minimize pulsation artifacts (white arrow), adding a posterior saturation band to eliminate susceptibility from air and bone posterior to neck soft tissues (black arrow) and imaging carried out in two groups in the upper (face; black arrowheads) and lower neck (white arrowheads), with two different shimming blocks to compensate for different tissue part thickness. DWI: diffusion-weighted imaging. that imaging should be done ahead of biopsy, not only to avoid the induced edema which will affect the measured ADC values, but also because of the risk of hemorrhage (iron content) inducing a local susceptibility artifact, thereby destroying the signal in this area.
DCE T1-weighted MRI: background and important technical considerations
This technique provides a non-invasive assessment of microcirculatory characteristics of lesions by quantifying the time course of contrast enhancement of DCE-MRI. 5 An IV injection of gadolinium-based contrast medium (gadopentate dimeglumine sodium) at a rate of 3 ml /s, and a dose of 0.1 mmol/kg (up to 20 ml contrast medium) is usually delivered by power injection through 18-20-gauge needle, followed by a 20 ml postcontrast saline flush. A fast 3D T1-weighted gradientecho SPGR (e.g. Vibe, FLASH, LAVA) MRI axial scan of 3-4 mm thickness corresponding to the same locations and thickness of axial T1 and T2-weighted anatomical images is carried out, with timings adjusted to acquire four pre-contrast runs followed by sequential post-contrast runs. For semiquantitative analysis, a temporal resolution of about 8-10 s through the area of interest in the head and neck is sufficient, whereas for model-based quantitative analysis (Tofts) a higher temporal resolution of 3-4 s is essential. Depending on the amount of wash-out to be visualized, the scan often takes up to 300-500 s (usually with 30 to 40 scan acquisitions; time points) and the curve acquired can then be analyzed. 5, 6 DCE-MRI curve semi quantitative analysis DCE-MRI is based on rapid diffusion of a low molecular weight diffusible MRI contrast medium (CM), a gadolinium chelate-based agent (Gd-DTPA), between the intra and extravascular compartments, resulting in a T1 relaxivity SI change (C) over time (t), (C/t). The measured T1 SI relates to the vascular density (S) within the lesion and is affected by regional blood flow (F) and permeability (P). The rate of enhancement relates to vascular permeability and leakiness (interstitial environment diffusibility and temporary retention of CM). 7 Similar to DWI, DCE-MRI should be carried out before biopsy to avoid induced alterations in the tissue environment.
Data obtained directly from a time-signal intensity curve measure the relative SI (RSI) post-contrast relative to pre-contrast (SI post À SI pre/SI pre), which is plotted against time (t) to get an RSI/t curve. The maximum SI (C-Peak) measures the degree of enhancement, whereas time to peak (TTP) and initial slope (IS) reflects the rate of enhancement (Figure 3 ). Both the SI maximum and the slope of enhancement shows a significant correlation with micro-vessel density and median tumor partial pressure of oxygen. In other words, the DCE curve correlates with angiogenesis and oxygenation. [7] [8] [9] Although the flow (F), permeability (P), and vascular density (S) components cannot be separated by mathematical modeling, their combined effect is reflected in the transfer constant (K trans ) characterizing the influx of CM from the plasma into the tissue extracellular space. Additional tissue-specific parameters Figure 3 . Post-IV contrast dynamic enhancement curve: The height between yellow dashed lines along the vertical axis represents the contrast SI peak (C-peak), the distance between red dashed lines along horizontal axis represents TTP, the steepness of the contrast enhancement in blue represents IS and the wash-out of CM along the curve down slope in green represents the outflow. IS: initial contrast uptake slope; IV: intravenous; SI: signal intensity; TTP: time to peak. may be estimated by DCE including: the volume fraction of the extravascular extracellular space (v e ), the volume fraction of plasma in tissue (v p ), and the rate constant for efflux of CM back into plasma from the tissue extracellular space (k ep ). 10 In our experience, the majority of the malignant lesions had a post-contrast enhancement peak near to or >50% of the arterial input function peak.
DCE-MRI quantitative analysis
Unlike computed tomography (CT) perfusion, Gd concentration does not have a linear relation with the SI. This is because the effect of the contrast agent is based on its T1 relaxation, decreasing the effect on surrounding water protons. In contrast with semiquantitative analysis, quantitative metrics allow true physiological parameters, such as K trans and the initial area under the Gaussian curve at 60 or 90 s (IAUGC 60 or 90) to be assessed. However, with DCE-MRI, blood flow (BF) and blood volume (BV) are very rarely used, as the only way for BV not to be overestimated is if the CM does not leave the intravascular compartment. DCE-MRI quantitative analysis allows a common platform for DCE-MRI results from different centers. Moreover, quantitative parametric mapping can be potentially applied for different sub-volumes within the lesion. To apply quantitative analysis (Tissue 4D, Siemens) calculations, additional T1 measurements should be obtained. Since the effect of the contrast enhancement signal change is a property of T1 relaxation, a voxelwise tissue (T10) is calculated prior to DCE runs by adding a T1-weighted SPGR-type sequence with different flip angles to calculate the T1 map (we usually apply the same VIBE sequence as the DCE, with three different flip angles 5, 10 and 15 before the contrast acquisition, each taking about 7-10 s). Alternatively, a T1W-inversion-recovery prepared turbo fast lowangle shot 3D sequence with several different inversion times (0.06, 0.2, 0.4, 0.8, and 1.6 s) can be applied. The T1 value from this series are used to quantify the T1map voxel-wise tissue (T10). 10 A pharmacokinetic model (Tofts model) is used to fit the enhancement curves that enable the calculation of physiological parameters. The Tofts model considers the extravascular extracellular space (EES) tissue (t) and plasma (p) as two compartments individually well mixed with contrast agent concentrations (C). Permeability from Ct to Cp and are described by transfer rate constants K trans and k ep , respectively ( Figure 5 ).
11
Tissue C t is obtained from a ROI (SI) placed on the tumor and plasma C p (arterial input function) is obtained from the ROI (SI) on a major vessel; the transport between these two compartments is determined by vascular permeability constants K trans and k ep . K trans is the volume transfer constant between plasma and EES and from EES to plasma respectively.
Another parameter is the EES fractional volume (v e ) related to the two other parameters by the equationv e ¼ K trans =k ep . If the contrast uptake is flow-limited, K trans indicates the tissue perfusion/unit volume. If the contrast uptake is permeability-limited, then K trans indicates the permeability surface area per unit volume of tissue. In real life, K trans reflects both tissue perfusion and permeability. The transfer constant k ep correlates with micro-vessel density and both K trans and k ep correlate with vascular endothelial growth factor (VEGF). [6] [7] [8] [9] DCE curve changes during successful therapy Early on during successful chemoradiotherapy (CRT; i.e. initial response), there is a decrease in the number of fast leaky components of the vascular wall resulting in a slower rise of the CM enhancement curve (a decrease in the rate of enhancement). With continued successful response to therapy (i.e. continued response), there is a regression of tumor angiogenic properties resulting in a decreased contrast peak. Simultaneously, fibrosis and other therapeutic effects also occur, resulting in re-diffusion with slower and gradual trapping (wash-in or accumulation pattern of enhancement; Figure 6 ). Functional changes in the vascular fenestration due to treatment effects leads to changes in the time-intensity curve from a rapid rise and wash-out in the pretreatment state to a slow rise and wash-in post-treatment state.
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Current and potential applications of functional MRI in head and neck cancer imaging Functional MRI in the evaluation of head and neck cancer can be discussed under the subheadings of seven applications given in Table 1 . 1. Resolving controversial scenarios in the diagnosis of primary cancer DWI and PWI can discriminate malignant from nonmalignant lesions because of the different tissue composition and neoangiogenic properties. By applying dynamic post-contrast CT perfusion (CTP), head and neck cancer showed an increased BF, BV, and decreased mean transit time (MTT) compared with benign lesions and normal tissue. 15 In CTP, MTT was found to best discriminate malignant from non-malignant tissue, with an average MTT of 3.5 s for malignant Table 1 . Applications of functional magnetic resonance imaging in the evaluation of head and neck cancer.
1.
Resolving controversial scenarios in the diagnosis of primary cancer.
2.
More precise gross tumor volume delineation: Differentiation of primary tumor from associated inflammatory changes. 3.
Staging issues: Bone/cartilage invasion, vascular and prevertebral muscle involvement. 4.
Pretreatment prediction of response. 5.
Intra-treatment response assessment. 6.
Early (2 weeks) post-Rx: Response assessment for salvage management; specifically of locally advanced disease T3/4 tumor. 7.
Differentiation of early post-therapy changes from Rx failure: Residual versus post-therapy non-tumorous inflammatory changes.
versus an MTT of 5.5 s for non-malignant tissue. 16, 17 Similarly, DWI showed more restricted diffusion in tumors as compared with normal tissue and reactive inflammatory tissue. 18 Upper aerodigestive tract inflammatory lesions are not infrequently encountered, and in some instances can pose a diagnostic dilemma to differentiate from neoplasia, with the final decision being made at pathological examination. However, functional MRI of the head and neck in our experience was able to confidently discriminate such cases ( Figure 7 ).
Changes associated with malignant lesions such as submucosal fibrosis of the buccal mucosa, often induced by chronic tobacco chewing, remains a big challenge to Figure 7 . A 63-year-old female patient with known breast cancer under treatment, presented with a recent complaint of increasing dysphagia, dysphonia and no fever. On endoscopy, bulge and edema suggested a posterior hypopharyngeal mass lesion. Axial CT scan (a) shows a thickening and enhancement of the right pyriform sinus and right sided posterior hypopharyngeal wall. Axial T2W-MRI (b) shows corresponding bright signal intensity, DWI at b0 (c) shows bright signal intensity, b1000 (d) shows a faint increased residual signal abnormality and ADC map (e) shows high ADC signifying facilitated rather than restricted diffusion. DCE-MRI curve (f) from the lesion (dashed line) shows early peak with steep slope. However, the contrast enhancement curve peak remains well below 50% of AIF curve peak (AIF curve denoted by solid line), with gradual pooling rather than wash-out, signifying an inflammatory lesion. In our experience, the majority of the malignant lesions have post-contrast enhancement peak near to or >50% of the arterial input function peak. The lesion subsequently resolved on steroids and antibiotics. ADC: apparent diffusion coefficient; AIF: arterial input function; CT: computed tomography; DCE: dynamic contrast-enhanced; DWI: diffusion-weighted imaging; MRI: magnetic resonance imaging. differentiate both clinically and with conventional imaging. In such case scenarios, the extent of the lesion and the need for surgical intervention is in question. In our experience, functional MRI of the head and neck has shown the potential in differentiating malignancy from adjacent submucosal fibrosis (Figure 8 ).
Extent of local disease: Gross tumor volume delineation
Gross tumor volume (GTV) denotes the tumor visible on clinical examination or delineated by radiological evaluation. Ill definition of tumor borders because of tumor-associated inflammatory changes and edema on morphological images is a well-recognized problem for GTV assessment. For example, the sole utilization of CT simulation scans in contouring of GTV is subject to a large degree of interobserver variability (53%), and co-registration of MRI and planning CTs substantially improved the interobserver delineation of target volume based on better delineation on MRI. 19, 20 The addition of functional MRI for tumor assessment can aid in more accurate GTV delineation by excluding the surrounding reactive inflammatory changes ( Figure 9) .
Moreover, subtleness of signal abnormality on morphologic images is commonly encountered with squamous cell carcinoma in such anatomical sites such as the larynx and oral cavity, with poor delineation that poses difficulty in staging. Functional MRI (DWI, DCE-MRI) can better delineate the tumor volume at these sites (Figure 10 ).
Staging issues
In the experience of the authors, decision making for certain staging issues can be further strengthened by evaluating the functional MRI images. Examples for Figure 9 . Added precision of functional MRI in GTV delineation in a case of carcinoma of right side of the tongue base, minimally extending to the posterior aspect of oral tongue. Routine morphologic spin echoes T1WI(a) and T2WI (b) show ill definition of the mass lesion (arrows), due to the surrounding peritumoral inflammatory changes and edema. DWI (c) from left to right hand side of image b0, b1000 and ADC map respectively, shows a smaller but better demarcated lesion (arrows), especially on the high b-value and the ADC map. Selected images from sequential post-contrast DCE-MRI (d) from left to right side of image, at early arterial, late arterial, venous and equilibrium phases show best delineation of lesion at the wash-in at late arterial phase. Note that the lesion appears to be mildly smaller on ADC than on DCE-MRI, probably due to increased perfusion related to tumor vascularity exceeding the restricted diffusion related to tumor cellularity. ADC: apparent diffusion coefficient; CT: computed tomography; DCE: dynamic contrast-enhanced; DWI: diffusion-weighted imaging; GTV: gross tumor volume; MRI: magnetic resonance imaging.
this are laryngeal cartilage and bone (cortical and marrow) invasion assessment ( Figure 11 ).
There is also a potential that DCE-MRI color maps, fused with morphologic T2/T1WI would be more specific in differentiating between stages T3/T4a/ T4b. This co-registration could improve the diagnosis of bone cortex and marrow invasion, vascular involvement and extension into surrounding soft tissue structures such as the prevertebral muscles ( Figure 12 ).
Prediction of tumor response by pretreatment tissue probing
Pretreatment tumor oxygenation is prognostic of locoregional tumor control after radiation therapy (RT) in advanced head and neck squamous cell carcinomas. 21 The 2-year control rate of head and neck cancer treated with radiotherapy correlates with the initial pimonidazole-binding level of the tumor, where high pimonidazole-binding (hypoxic) tumors had significantly lower control rates of 48% compared with 87% for tumors with low pimonidazole-binding. 22 DCE metrics such as K trans , k ep , initial area under the curve at 90 s (IAUC90), BV, and BF showed a significant correlation with the uptake of pimonidazole in tumors. This denotes that tumor vasculature is a surrogate marker for oxygenation state, and accordingly can be used to predict post-treatment outcomes in head and neck cancer. [22] [23] [24] Agarwal et al. 25 demonstrated that BF and BV were significantly higher in patients with a high T-stage (T3, T4) head and neck cancer and showed a better response to CRT.
Using pretreatment CTP, Truong et al. 11 showed that pretreatment tumor BF was significantly higher in patients who achieved locoregional control (LRC), 118.0 ml/100 g/min, compared with those with locoregional failure (LRF), 53.4 ml/100 g/min.
Agarwal et al., 25 Kim et al., 26 and Chawla et al. 27 studied the role of DCE-MRI metrics as predictors of response in head and neck cancers to CRT and showed that head and neck cancer with higher pretreatment BV, and pretreatment K trans correlated with better response to CRT and disease-free survival.
Similarly, DWI can be used as a pretreatment marker for tumor hypoxia. Pretreatment head and neck cancers with necrosis due to tumor hypoxia and decreased vascularity have higher ADC values, and are less responsive to chemotherapy (CT) and RT. On the other hand, pretreatment head and neck cancers with higher BF and vascular permeability have better oxygenation with better access to CT and better response to RT. 28 Kim et al. 29 studied the efficacy of pretreatment DWI and early intra-treatment DWI changes in predicting the response of locally advanced head and neck squamous cell carcinoma to concurrent CRT and showed that DWI of head and neck cancer before treatment can predict the response to CRT There is an associated abnormal intermediate signal intensity in the anterior 1/3 of left laryngeal cartilage on T1, bright signal intensity on T2 and enhancement on post-contrast images, concerning for probable laryngeal cartilage invasion (arrows in a, b, and c). DWI images (d) from left to right hand side at b0, b1000 and ADC map shows that the lesion has a bright signal on b0 and b1000 with T2 shine-through on an ADC map image, consistent with PTNT inflammatory tissue next to the inner cortex of thyroid cartilage (arrows). DCE-MRI post CM perfusion (e) 10 s coverage (time point) sequential phases; 7 th , 12 th , 30 th phases during early arterial, venous, and tissue equilibrium phases respectively showing gradual low peak enhancement of PTNT next to the inner cortex of thyroid cartilage; not extending into the cartilage. The patient was disease-free on clinical and MRI follow up after 1 year. CRT: chemo-radiotherapy; ADC: apparent diffusion coefficient; PTNT: post therapy non-tumorous; DCE: dynamic contrast enhanced.
Kato et al. 30 in their cohort of patients with head and neck squamous cell carcinoma, evaluated DWI MRI for the prediction of response to neoadjuvant therapy. They found that the tumors that responded well to neoadjuvant therapy tended to have lower ADC values, which they attributed to higher cellularity and higher cellular turnover, and the quantitative and qualitative signal intensities of the lesions on DWI showed positive correlations (r ¼ 0.367 and 0.412, respectively, p < .05) with the tumor regression rates.
Initial/intra-treatment response prediction
CRT leads to cell death and reduction of the restrictive barriers, resulting in increase in mean ADC values early in the course of treatment. Early change of ADC after CRT for treatment of squamous cell carcinoma of the head and neck was studied by different authors. The change in ADC at 1 week of CRT was studied by Kim et al. and showed 86% sensitivity and 83% specificity for prediction of treatment response. 29 The study at 2 weeks after induction CT by Berrak et al. 31 showed that a 22% increase in ADC compared with pretreatment ADC was associated with better posttherapy response and long-term survival.
According to Vandecaveye et al., the change in DWI at 2 and 4 weeks during concomitant CRT (% increase in ADC (ÁADC)) showed substantially greater accuracy than volumetric assessment for differentiation between responding and non-responding lesions at 2 years posttherapy. The ÁADC at 2 weeks was significantly lower for lesions with post-CRT recurrence than with complete remission (in %; primary tumor: 1.6 AE 9.7 versus 40.5 AE 25.6; and adenopathies: 10.9 AE 26.0 versus 52.1 AE 36.5, both p < 0.001). 32 Early response to therapy also results in decrease in vascular permeability of the neoangiogenic vessels, leading to decrease in the rate of enhancement. Powel et al. evaluated DCE parameters at 1 week after induction chemotherapy. In their cohort of patients, they compared the change of K trans and the initial area under the curve at 60 s (IAUC60) between non-responders and responders, with the responders group showing a significant decrease of K trans and IAUC60 posttreatment compared with pretreatment, falling by approximately 50%. 33 6. Prediction of response after completion of treatment (continued successful therapy) DCE-MRI metric changes after the completion of radiotherapy reflect a reduction of vascular density, with a decrease in the overall SI and repair of treated tissue with changes in the vascular fenestration resulting in CM trapping. 18 Knopp et al. applied DC-MRI at around 8 weeks after completion of CT/RT to predict the outcome and was successful in identifying patients at risk of local recurrence as candidates for dose escalation or salvage surgery. In their cohort of patients, those with local recurrence showed a high initial peak CP value and a short TTP (steep slope on the t-SI curve), whereas patients with local control showed a slow rise and a continuous wash-in accumulation pattern ( Figure 13 ). Similarly, an early DWI 3-4 weeks after completion of CT/RT can predict long-term outcomes ( Figure 13 ). Vandecaveye et al., examined the percentage change of ADC at 3 weeks post-treatment between responding and non-responding lymph nodes in correlation with the outcome after 2 years of follow up. It was shown that there was a significant increase in the percentage change of ADC % at 3 weeks in patients with continued successful therapy and subsequent remission as compared with patients with subsequent recurrence; and showed higher specificity and positive predictive value for early identification of risk of recurrence as compared with a CT scan at 3 months. 33 
Differentiating a recurrent tumor from a posttherapy non-tumorous lesion
Vascular changes associated with a recurrent tumor (rT) represent neoangiogenesis, whereas post-therapy non-tumorous (PTNT) lesions shows vascular changes of continued successful therapy and fibrosis. These changes in PTNT lesions leads to a high ADC in DWI, whereas locoregional failure with tumor recurrence leads to restricted diffusion, with a subsequent decrease in ADC. 34 Using contrast-enhanced CT quantitative measurements of perfusion and permeability, Bisdas et al. showed that the mean BF of an rT was 69.71 ml/min/100 g whereas the mean of PTNT lesions was 45.31. 35 Vandecaveye et al. 36 used DWI to differentiate an rT from PTNT lesions in their cohort of patients with head and neck squamous cell carcinoma. The SI on b0 and b1000 of DWI was significantly lower and higher respectively for rT than for PTNT with resulting ADC values significantly lower for rT than for PTNT (p < 0.0001), with a sensitivity of 94.6%, specificity of 95.9%, and accuracy of 95.5% (Figure 14) . In the same clinical scenario of cancer treatment with CRT, patients may present for follow up with a tumefactive lesion related to the treatment site. It is difficult in most instances to characterize the lesion by using conventional imaging and typically, biopsy is sought to solve the mystery. However, based on the above principles, both DWI, and post-contrast DCE-MRI have the potential of better detecting as well as differentiating rT from PTNT changes 37 ( Figure 15 ).
Limitations and future applications
The first limitation is that metastatic squamous cell carcinoma lymph nodes (LNs) are heterogeneous with solid and variable degree of necrotic or micronecrotic areas, which makes it hard to have reproducible measurements between different centers, as the heterogeneity leads to higher inter-and even intra-observer variability which is a source for conflicting results in their characterization using DCE-MRI or DWI. In a study by Zhang et al., the mean ADC value of solid and necrotic portions of metastatic squamous cell carcinoma LNs 39 This has led to overlapping results in the literature between metastatic and reactive LNs. 40, 41 Similarly, the limitation of DCE-CT parameters in differentiating benign and malignant LNs was demonstrated by Bisdas et al. 35 The second limitation is related to the heterogeneity of the tumor response to treatment. CRT can reduce the bulk of tumor burden, but small regions of the tumor might not respond to ongoing treatment. These areas of local failure can be the reason why the assessment of tumor using morphological criteria may be misguiding. A promising solution to this is the delineation of tumor sub-volumes using parametric mapping information, voxel-by-voxel mapping of histogram analysis distribution of ADC values as well as DCE-MRI quantitative parameters within different ROIs, which could result in tumor dose painting and will have a substantial impact on patient management. 42, 43 Lastly, functional MRI correlation with tumor immunohistochemistry biomarkers has received little attention. However, it is very likely that, by applying parametric ADC mapping and quantitative physiological perfusion parametric mapping, it will be possible to correlate tumor parameters with immunohistochemical features, for example ADC with HER2 (human epidermal growth factor 2) expression for assessment of cell proliferation, and K trans and k ep with COX-2 (cyclo-oxygenase 2) expression, and VEGF for angiogenesis. 44 
Conclusion
Functional MRI including DWI and DCE-MRI of head and neck cancers has become a feasible effective diagnostic tool with little additional time on the scanner. It can be advantageous to sort out diagnostic and staging issues like tumor delineation, tumor extension with differentiation of T3-T4a-T4b stages, and the prediction of tumor response by identifying intra-and early post-treatment biological changes in functional MRI before morphological alterations parameters can predict a prognostic outcome. However, the most important point is that these advanced imaging studies can provide clues into biological behavior, including post-therapy changes, failure of response or recurrence of a lesion which can direct clinicians on further management. For example, if the advanced imaging features indicate post-treatment changes, the lesion can be safely followed up. On the other hand, if the advanced MRI suggest a malignant lesion, it could be used to guide a biopsy. Figure 15 . Recurrent buccal CA, surgery and radiotherapy ended 2 years back; the patient was then complaining of swelling in the upper gum. The soft tissue abnormality seen in the right gingiva is subtle on morphologic T1W, T2W and T1W fat-suppressed post-IV gadolinium (a, b, and c respectively) images in the top row. In contrast, there is more precise delineation on DWI b0, b1000, and ADC map (d, e, and f respectively) images in the bottom row, measuring 440 a.u., 164 a.u., and 0.9 (Â10 À3 mm 2 /s) respectively (tumor demonstrated by arrow in a, b, c, d, e, and f). Post-contrast dynamic DCE-MRI curve (g) shows abnormal curve (dotted line denoted by short arrow) with early peak enhancement and a perfusion peak >50% AIF (solid line curve denoted by long arrow), and gradual wash-out, confirming the clinical suspicion of a recurrent tumor. CA: cancer; DWI: diffusion weighted imaging; ADC: apparent diffusion coefficient; DCE: dynamic contrast enhanced; AIF: arterial input function.
